Загрузка...
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
Ecteinascidin 743 (ET-743), a highly promising marine-based antitumor agent presently in phase II clinical trials, has been shown to interfere with the binding of minor-groove-interacting transcription factors, particularly NF-Y, with their cognate promoter elements in vitro. We have shown that NF-Y...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
National Academy of Sciences
2000
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC18735/ https://ncbi.nlm.nih.gov/pubmed/10841572 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|